Tiens Biotech Group

Tiens Biotech Group USA Inc., Ticker (TBV), operates primarily through its China-based subsidiary Tiens Biological Development CO. Ltd. Tiens Biological has developed and produced seven major product series, of which six comprise nutrition supplement products, and the seventh comprises personal care products. It develops its products at its own product research and development center and conducts the marketing and sales of its products through its affiliated company, which owns 23 branches, representative offices and chain stores. The company's stock is traded on the American Stock Exchange.

Additional recommended knowledge

Better weighing performance in 6 easy steps

Recognize and detect the effects of electrostatic charges on your balance

Daily Sensitivity Test

Joint venture

The company entered into a joint venture with Tianjin Tianshi Pharmaceutical Co., Ltd. in 2004 :

In April 2004 Tiens' wholly-owned subsidiary, Tianshi International Holding Group Ltd. entered into a joint venture agreement with Tianjin Tianshi Pharmaceutical Co., Ltd. to establish Tiens Yihai, a Chinese-Foreign Equity Joint Venture. Located in Shanghai,China, Tiens Yihai is in the business of research and development, production and marketing of nutrition supplements products, home care and personal care products. The total investment amount is projected to be approximately $400million.^[1]

References

1. ^ About Tiens, company website, 2005.

See also

• Pharmaceutical industry in China

[Sri lanka tiens group][http://www.linksl.com]